Other
Gastrointestinal Function
0
Pipeline Programs↗
1
Active Trials↗
2
Companies Involved↗
Gastrointestinal Function is an early-stage landscape with 0 programs across 2 companies. The most active players are Helsinn Therapeutics (U.S.), Inc, Newsoara Biopharma Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
11
clinical trials
Completed6 · 55%
Unknown status3 · 27%
Terminated1 · 9%
Not yet recruiting1 · 9%
Clinical Trials
Trial Activity
11 trials
Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function
Unknown status·TThe First Affiliated Hospital with Nanjing Medical University·N/A·NCT04295109·105 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)